User profiles for Mahima Thapa
 | Mahima ThapaMichigan State University Verified email at msu.edu Cited by 2699 |
[HTML][HTML] SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses
SARS-CoV-2 mRNA-based vaccines are about 95% effective in preventing COVID-19 1, 2, 3,
4, 5. The dynamics of antibody-secreting plasmablasts and germinal centre B cells …
4, 5. The dynamics of antibody-secreting plasmablasts and germinal centre B cells …
[HTML][HTML] SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2
In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast-derived
mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal …
mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal …
[HTML][HTML] Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the global
COVID-19 pandemic. Rapidly spreading SARS-CoV-2 variants may jeopardize newly …
COVID-19 pandemic. Rapidly spreading SARS-CoV-2 variants may jeopardize newly …
Effect of immunosuppression on the immunogenicity of mRNA vaccines to SARS-CoV-2: a prospective cohort study
…, RE Schriefer, SE Sides, M Thapa… - Annals of internal …, 2021 - acpjournals.org
Background: Patients with chronic inflammatory disease (CID) treated with immunosuppressive
medications have increased risk for severe COVID-19. Although mRNA-based SARS-…
medications have increased risk for severe COVID-19. Although mRNA-based SARS-…
[HTML][HTML] Germinal centre-driven maturation of B cell response to mRNA vaccination
Germinal centres (GC) are lymphoid structures in which B cells acquire affinity-enhancing
somatic hypermutations (SHM), with surviving clones differentiating into memory B cells (MBCs…
somatic hypermutations (SHM), with surviving clones differentiating into memory B cells (MBCs…
[HTML][HTML] SARS-CoV-2 variants show resistance to neutralization by many monoclonal and serum-derived polyclonal antibodies
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the global
COVID-19 pandemic infecting more than 106 million people and causing 2.3 million deaths. The …
COVID-19 pandemic infecting more than 106 million people and causing 2.3 million deaths. The …
[HTML][HTML] Glucocorticoids and B cell depleting agents substantially impair immunogenicity of mRNA vaccines to SARS-CoV-2
…, DC Perantie, RE Schriefer, SE Sides, M Thapa… - MedRxiv, 2021 - ncbi.nlm.nih.gov
Background: Individuals with chronic inflammatory diseases (CID) are frequently treated
with immunosuppressive medications that can increase their risk of severe COVID-19. While …
with immunosuppressive medications that can increase their risk of severe COVID-19. While …
[PDF][PDF] A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants
The emergence of SARS-CoV-2 antigenic variants with increased transmissibility is a public
health threat. Some variants show substantial resistance to neutralization by SARS-CoV-2 …
health threat. Some variants show substantial resistance to neutralization by SARS-CoV-2 …
[HTML][HTML] A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variants
The emergence of antigenically distinct severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants with increased transmissibility is a public health threat. Some of these …
variants with increased transmissibility is a public health threat. Some of these …
[HTML][HTML] The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing antibodies and targets both the NTD and the RBD
In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast
derived mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal …
derived mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal …